Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre(Friedrich-Alexander-Universität Erlangen-Nürnberg), Georg Schett(Karolinska University Hospital), Wolfgang Baum(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hans Ulrich Scherer(Leiden University), Roland Axmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Elena Neumann(Allgemeines Krankenhaus Celle), Anca I. Catrina(Karolinska University Hospital), Grit Krumbholz(University of Hildesheim), René E. M. Toes(Leiden University Medical Center), Elena Ossipova(Karolinska University Hospital), Gabriella Sármay(Eötvös Loránd University), Lars Klareskog(Karolinska University Hospital), Aline Bözec(Center for Rheumatology), Falk Nimmerjahn(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dan Georgess(École Normale Supérieure de Lyon), Holger Bang, Eszter Szarka(Eötvös Loránd University), Per‐Johan Jakobsson(Karolinska University Hospital), Pierre Jurdic(École Normale Supérieure de Lyon)
Cited by 708
Related Papers
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination
|Arthritis & Rheumatism|2005|1.5k
<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
|New England Journal of Medicine|2007|1.1k